APHIG: a new multiparameter index for prostate cancer

APHIG: a new multiparameter index for prostate cancer

Serum of 336 patients with primary prostate cancer (PC) with baseline total prostate-specific antigen level (totPSA) < 30.0 ng/ml was tested for free PSA (freePSA) and [-2]proPSA; %freePSA, %[-2]proPSA, prostate health index (phi), and a new index APHIG calculated using lab tests and taking i...

Full description

Bibliographic Details
Main Authors:	N. S. Sergeeva, T. E. Skachkova, B. Ya. Alekseev, E. F. Yurkov, S. A. Pirogov, V. G. Gitis, N. V. Marshutina, A. D. Kaprin
Format:	Article
Language:	Russian
Published:	ABV-press 2016-12-01
Series:	Onkourologiâ
Subjects:	indolent and aggressive prostate cancer prostate-specific antigen totpsa freepsa [-2]propsa prostate health index
Online Access:	https://oncourology.abvpress.ru/oncur/article/view/587

Similar Items

Investigation of correlations between different prostate-specific antigen forms and clinical and morphological characteristics of a tumor process in patients with prostate cancer
by: N. S. Sergeeva, et al.
Published: (2015-06-01)

The validation of threshold decision ruls and calculator for APhiG algoritm for clarification of prostate cancer staging before treatment
by: N. S. Sergeeva, et al.
Published: (2020-04-01)

Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography
by: Guo-Peng Yu, et al.
Published: (2016-01-01)

DIAGNOSTIC VALUE OF DEFINITION OF FRACTIONS OF PROSTATIC SPECIFIC ANTIGEN AND PROSTATE HEALTH INDEX
by: A. S. Al-Shukri, et al.
Published: (2017-04-01)

Diagnostic value of [-2]proPSA and PHI index (review of literature)
by: A. V. Sidorenkov, et al.
Published: (2014-12-01)

Diagnostic value of [-2]proPSA and PHI index (review of literature)
by: A. V. Sidorenkov, et al.
Published: (2014-12-01)

THE CORRELATION BETWEEN SERUM PSA LEVEL AND PROSTATE HISTOLOGIC AGGRESSIVENESS WITH PROSTATIC VOLUME IN BPH PATIENTS
by: Gede Wirya Kusuma Duarsa, et al.
Published: (2019-01-01)

CLINICAL SIGNIFICANCE OF BIOMARKERS IN OVARIAN CANCER, PROSTATE CANCER, COLORECTAL CANCER
by: N. V. Marshutina, et al.
Published: (2016-03-01)

Differential DNA Methylation in Prostate Tumors from Puerto Rican Men
by: Gilberto Ruiz-Deya, et al.
Published: (2021-01-01)

Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput <i>N</i>-Glycan Profiling
by: Sarah Gilgunn, et al.
Published: (2020-12-01)

The validation results for APhiGT algorithm for clarification of prostate cancer staging before treatment (first step)
by: N. S. Sergeeva, et al.
Published: (2019-07-01)

USE OF PROSTATIC SPECIFIC ANTIGEN AS A PREDICTOR OF THE LONG-TERM RESULTS OF BRACHYTHERAPY FOR PROSTATE CANCER
by: S. A. Ivanov, et al.
Published: (2014-08-01)

USE OF PROSTATIC SPECIFIC ANTIGEN AS A PREDICTOR OF THE LONG-TERM RESULTS OF BRACHYTHERAPY FOR PROSTATE CANCER
by: S. A. Ivanov, et al.
Published: (2014-08-01)

Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients
by: Antonio B. Porcaro, et al.

Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
by: Sinan Avci, et al.
Published: (2020-04-01)

Moving ahead of prostate-specific antigen
by: Banyameen Mohamad Iqbal, et al.
Published: (2016-01-01)

Association of prostate volume with incidence and aggressiveness of prostate cancer
by: Al-Khalil S, et al.
Published: (2016-10-01)

Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review
by: Arslaan Javaeed, et al.
Published: (2020-05-01)

Is It Effective to Perform Two More Prostate Biopsies According to Prostate-Specific Antigen Level and Prostate Volume in Detecting Prostate Cancer? Prospective Study of 10-Core and 12-Core Prostate Biopsy
by: Byung Il Yoon, et al.
Published: (2012-05-01)

DIAGNOSIS OF PROSTATIC NEOPLASM LATER TO ANTIBIOTIC TREATMENT IN PATIENTS WITH PROSTATE-SPECIFIC ANTIGEN BETWEEN 4 AND 10 ng/ml (IN SPANISH)
by: Infantes-Burgos Ronald Javier, et al.
Published: (2014-01-01)

The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer
by: Bai X, et al.
Published: (2020-08-01)

Analysis of the Correlationship between Prostate Specific Antigen Related Variables and Risk Factor in Patients with Prostate Carcinoma
by: Daoyuan Wang, et al.
Published: (2015-01-01)

The results of transrectal prostate biopsy in patients with low levels of prostate specific antigen
by: Ahmet Ali Sancaktutar, et al.
Published: (2012-06-01)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
by: Ahmad Anies Shahab, et al.
Published: (2013-03-01)

Efficacy of Prostate-Specific Antigen to Categorize Men with Prostate Pathology into Benign, Premalignant, and Malignant Lesions
by: Raja Parthiban, et al.
Published: (2016-06-01)

Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
by: Rodolfo Montironi, et al.
Published: (2020-04-01)

Study of prostatic pathology and its correlation with prostate specific antigen level
by: S Hirachand, et al.
Published: (2017-03-01)

Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms
by: Michael Tzeng, et al.
Published: (2021-08-01)

THE INCIDENCE AND CORRELATION OF CHRONIC PROSTATITIS WITH PSA IN BPH PATIENT
by: Daniel Mahendra Krisna, et al.
Published: (2018-07-01)

Incidence of histological prostatitis and its correlation with PSA density
by: Affonso Celso Piovesan, et al.
Published: (2009-11-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

PROSTATE SPECIFIC ANTIGEN LEVEL FOLLOWING TRANSURETHRAL RESECTION OF THE PROSTATE
by: Johannes Aritonang, et al.
Published: (2020-01-01)

Relationship of Prostate-Specific Antigen (PSA) and Prostate Volume in Patients with Biopsy Proven Benign Prostatic Hyperplasia (BPH)
by: Aulia Nur Fadila, et al.
Published: (2020-07-01)

CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS
by: Daniel Simanjuntak, et al.
Published: (2016-03-01)

The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen
by: Hee Ju Cho, et al.
Published: (2014-12-01)

Evaluation of Prostate specific antigen levels and its correlation with histopathological findings
by: Sujata Pudasaini, et al.
Published: (2019-03-01)

Metastatic prostate cancer in the modern era of PSA screening
by: Philip A. Fontenot Jr, et al.

Beyond prostate-specific antigen: alternatives for prostate neoplasm screening
by: Yu, Kevin Kuo-Han
Published: (2016)

THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER
by: A. A. Gritskevich, et al.
Published: (2017-02-01)

Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values
by: Hasan Yilmaz, et al.
Published: (2015-06-01)

Cannot write session to /tmp/vufind_sessions/sess_okfsogsg1bnhbmmsd70j6a9f6a